Scarica l'app Stockscreener
18.53
5.22%
0.92
Dopo l'orario di chiusura:
18.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OM Giù?
Forum
Previsione
Precedente Chiudi:
$17.61
Aprire:
$17.86
Volume 24 ore:
172.44K
Relative Volume:
0.52
Capitalizzazione di mercato:
$328.39M
Reddito:
$114.73M
Utile/perdita netta:
$-140.94M
Rapporto P/E:
-6.7138
EPS:
-2.76
Flusso di cassa netto:
$-126.18M
1 W Prestazione:
+6.37%
1M Prestazione:
-5.27%
6M Prestazione:
+45.28%
1 anno Prestazione:
-66.70%
Intervallo 1D:
$17.55
$18.63
Intervallo di 1 settimana:
$17.43
$19.45
Portata 52W:
$5.85
$58.50
Outset Medical Inc Stock (OM) Company Profile
Nome
Outset Medical Inc
Settore
Industria
Telefono
669-231-8200
Indirizzo
3052 ORCHARD DRIVE, SAN JOSE
Confronta OM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
18.53 | 312.09M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Iniziato | BTIG Research | Buy |
| 2024-04-05 | Aggiornamento | CL King | Neutral → Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-17 | Iniziato | CL King | Neutral |
| 2022-11-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-07-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Iniziato | Cowen | Outperform |
| 2021-04-19 | Iniziato | Wells Fargo | Overweight |
| 2020-12-16 | Iniziato | Oppenheimer | Perform |
| 2020-10-12 | Iniziato | Barclays | Overweight |
| 2020-10-12 | Iniziato | BofA Securities | Buy |
| 2020-10-12 | Iniziato | Goldman | Buy |
| 2020-10-12 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Outset Medical Inc Borsa (OM) Ultime notizie
Is Outset Medical Inc. a good long term investmentRapid capital growth - PrintWeekIndia
Shareholders that lost money on Outset Medical, Inc.(OM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
What drives Outset Medical Inc. stock priceExceptional market performance - Autocar Professional
Outset Medical Inc. Stock Analysis and ForecastSuperior trading gains - jammulinksnews.com
What analysts say about Outset Medical Inc. stockRapid profit acceleration - Autocar Professional
Does Outset Medical Inc. stock pay reliable dividendsInstant Stock Updates - newser.com
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - GlobeNewswire
Outset Medical Earnings: Dialysis Tech Pioneer Sets Q2 Results Date, Top Executives to Present - Stock Titan
Institutional investors may adopt severe steps after Outset Medical, Inc.'s (NASDAQ:OM) latest 14% drop adds to a year losses - simplywall.st
Outset Medical, Inc.'s (NASDAQ:OM) Latest 14% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures - 富途牛牛
Why Outset Medical’s Rock-Bottom Valuation Masks Explosive Growth (NASDAQ:OM) - Seeking Alpha
Top Companies in Smart Dialysis Systems (Jul, 2025) - Tracxn
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc. (OM) Shareholders - ACCESS Newswire
Outset Medical, Inc.(NasdaqGS: OM) added to Russell 3000 Value Index - MarketScreener
Outset Medical, Inc.(NasdaqGS: OM) added to Russell 2000 Growth Index - MarketScreener
Outset Medical Inc (OM) Shares Down 2.93% on Jun 27 - GuruFocus
Renee Gaeta Joins Outset Medical as Chief Financial Officer - Medical Product Outsourcing
FMS Stock Likely to Gain on New Optimization Plan FME Reignite - Yahoo Finance
Outset Medical Inc (OM) Shares Down 5.6% on Jun 17 - GuruFocus
Transcript : Outset Medical, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 11 - marketscreener.com
Outset Medical at Goldman Sachs Conference: Strategic Focus on Acute and Home Dialysis - Investing.com Canada
Outset Medical appoints Renee Gaeta as CFO - MedTech Dive
Outset Medical Inc (OM) Trading 3.49% Higher on Jun 5 - GuruFocus
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors Who Suffered Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Pending - ACCESS Newswire
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference | OM Stock News - GuruFocus
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
BTIG maintains buy rating on Outset Medical stock after CFO change By Investing.com - Investing.com South Africa
Outset Medical Appoints Renee Gaeta as Chief Financial Officer | - GuruFocus
TD Cowen Adjusts Price Target on Outset Medical to $25 From $15, Maintains Buy Rating - MarketScreener
Outset Medical Inc Azioni (OM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):